Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jie Qing Eu
Observed names:
J.Q. Eu,
Jie-Qing Eu
Institutions:
Nanyang Technological University,
Cancer Science Institute of Singapore
Observed institutions:
National University of Singapore,
Nanyang Technological University,
Cancer Science Institute of Singapore
ORCID:
0009-0008-4219-3513
Observed ORCID:
0009-0008-4219-3513
OpenAlex ID:
A5077346335
Do STAT3 inhibitors have potential in the future for cancer therapy?
2017
·
Andrea L.A. Wong
, Jayshree L. Hirpara
, et al.
·
Expert Opinion on Investigational Drugs
·
225
PDF
Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy
2020
·
Jiaqi Li
, Jie Qing Eu
, et al.
·
Molecules
·
159
Targeting STAT3 and oxidative phosphorylation in oncogene-addicted tumors
2018
·
Matilda Lee
, Jayshree L. Hirpara
, et al.
·
Redox Biology
·
127
PDF
Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance
2018
·
Jayshree Hirpara
, Jie Qing Eu
, et al.
·
Redox Biology
·
123
PDF
Interplay between Mitochondrial Metabolism and Cellular Redox State Dictates Cancer Cell Survival
2021
·
Brittney Joy-Anne Foo
, Jie Qing Eu
, et al.
·
Oxidative Medicine and Cellular Longevity
·
52
PDF
Targeting Cell Metabolism as Cancer Therapy
2019
·
Natalie Y.L. Ngoi
, Jie Qing Eu
, et al.
·
Antioxidants and Redox Signaling
·
51
Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies
2024
·
Jiaqi Li
, Justin Yi Shen Lim
, et al.
·
Antioxidants and Redox Signaling
·
37
Reactive Oxygen Species and Oncoprotein Signaling-A Dangerous Liaison
2017
·
Stephen Jun Fei Chong
, Jolin Xiao Hui Lai
, et al.
·
Antioxidants and Redox Signaling
·
31
Tumor-derived extracellular vesicles convey solute transporters to induce bioenergetic dependence shift contributing to treatment resistance
2024
·
Jayshree Hirpara
, Win Lwin Thuya
, et al.
·
Theranostics
·
12
PDF
BCL-2 dependence is a favorable predictive marker of response to therapy for chronic lymphocytic leukemia
2025
·
Stephen Jun Fei Chong
, Junyan Lu
, et al.
·
Molecular Cancer
·
9
Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHD
2023
·
Deepika Raman
, Charlotte Chêne
, et al.
·
Biology
·
5
PDF
Mitochondrial translocation of MDM2 and TFAM reprograms metabolism in treatment-refractory cancers
2026
·
Jie Qing Eu
, Nur Afiqah Binte Mohamed Salleh
, et al.
·
npj Precision Oncology
·
1
PDF
166P Integrative multi-omics refine molecular diagnostics in non-small cell lung cancer
2024
·
L.R. Kong
, I. Han
, et al.
·
Annals of Oncology
·
1
PDF
Evaluation of pharmacodynamic (PD) biomarkers in advanced cancer patients treated with oxidative phosphorylation (OXPHOS) inhibitor, OPC-317 (OPC)
2019
·
J.Q. Eu
, K. Yadav
, et al.
·
Annals of Oncology
·
1
Abstract 936: Temporal dependency of STAT3 signaling dictates hepatocarcinogenesis in metabolic dysfunction-associated steatohepatitis.
2026
·
Jie Qing Eu
, Nur Afiqah Binte Mohamed Salleh
, et al.
·
Cancer Research
25P Targeting STAT3-mediated liver pathogenesis through novel RNA therapeutics strategies
2025
·
J.Q. Eu
, N.A. Mohamed Salleh
, et al.
·
ESMO Open
Abstract 5807: MDM2 mitochondrial translocation mediates metabolic reprogramming towards OXPHOS in TKI-resistant oncogene-addicted cancer
2022
·
Jie Qing Eu
, Li Ren Kong
, et al.
·
Cancer Research
Show more works
View as search
Works count:
17
Citation count:
834
H-index:
9
I10-index:
9
Year
Topic
Type
